Published in
Lippincott, Williams & Wilkins, European Journal of Gastroenterology & Hepatology, 1S(33), p. e574-e579, 2021
DOI: 10.1097/meg.0000000000002166
Links
Tools
Infectious risk of vedolizumab compared with other biological agents in the treatment of inflammatory bowel disease
Journal article published in 2021 by
Tommaso Innocenti,
Jenny Roselli,
Erica N. Lynch 
,
Pasquale Apolito,
Laura Parisio,
Siro Bagnoli,
Giuseppe Macrì,
Francesca Rogai,
Mirko Tarocchi,
Stefano Milani,
Andrea Galli,
Monica Milla,
Gabriele Dragoni
,
Pasquale Apolito,
Laura Parisio,
Siro Bagnoli,
Giuseppe Macrì,
Francesca Rogai,
Mirko Tarocchi,
Stefano Milani,
Andrea Galli,
Monica Milla,
Gabriele Dragoni
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 